Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Anticipating rotavirus vaccines – a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13

Authors: Salem Alkoshi, Eyal Leshem, Umesh D Parashar, Maznah Dahlui

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Libya introduced rotavirus vaccine in October 2013. We examined pre-vaccine incidence of rotavirus hospitalizations and associated economic burden among children < 5 years in Libya to provide baseline data for future vaccine impact evaluations.

Methods

Prospective, hospital-based active surveillance for rotavirus was conducted at three public hospitals in two cities during August 2012 - April 2013. Clinical, demographic and estimated cost data were collected from children <5 hospitalized for diarrhea; stool specimens were tested for rotavirus with a commercial enzyme immunoassay. Annual rotavirus hospitalization incidence rate estimates included a conservative estimate based on the number of cases recorded during the nine months and an extrapolation to estimate 12 months incidence rate. National rotavirus disease and economic burden were estimated by extrapolating incidence and cost data to the national population of children aged <5 years.

Results

A total of 410 children <5 years of age with diarrhea were enrolled, of whom 239 (58%) tested positive rotavirus, yielding an incidence range of 418-557 rotavirus hospitalizations per 100,000 children <5 years of age. Most (86%) rotavirus cases were below two years of age with a distinct seasonal peak in winter (December-March) months. The total cost of treatment for each rotavirus patient was estimated at US$ 679 (range: 200–5,423). By extrapolation, we estimated 2,948 rotavirus hospitalizations occur each year in Libyan children <5 years of age, incurring total costs of US$ 2,001,662 (range: 1,931,726-2,094,005).

Conclusions

Rotavirus incurs substantial morbidity and economic burden in Libya, highlighting the potential value of vaccination of Libyan children against rotavirus.
Literature
1.
go back to reference Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, the WHOcGRSN, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41.CrossRefPubMed Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, the WHOcGRSN, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41.CrossRefPubMed
2.
go back to reference Hanane K, Isla O, El Khoury Antoine DY, Mireille G. Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population. BMC Infectious Diseases. 2009;11(1):9. Hanane K, Isla O, El Khoury Antoine DY, Mireille G. Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population. BMC Infectious Diseases. 2009;11(1):9.
3.
go back to reference NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. NCIDC: Surveillance department; 2009. p. 61–-64. NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. NCIDC: Surveillance department; 2009. p. 61–-64.
4.
go back to reference Gray J, Vesikari T, Damme V. Economic Burden of Rotavirus Disease. Health Protection Agency, London, UK, Journal of Pediatric Gastroenterology and Nutrition: Centre for Infections; 2008. Gray J, Vesikari T, Damme V. Economic Burden of Rotavirus Disease. Health Protection Agency, London, UK, Journal of Pediatric Gastroenterology and Nutrition: Centre for Infections; 2008.
5.
go back to reference WHO. Guidelines for estimating the economic burden of diarrhoeal disease with focus on assessing the costs of rotavirus diarrhoea. The Department of Immunization, Vaccines and Biologicals: WHO; 2005. p. 2–5. WHO. Guidelines for estimating the economic burden of diarrhoeal disease with focus on assessing the costs of rotavirus diarrhoea. The Department of Immunization, Vaccines and Biologicals: WHO; 2005. p. 2–5.
6.
go back to reference Cortese MM, Parashar UD, Centers for Disease C, Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Dept of Health & Human Services, Centers for Disease Control and Prevention. 2009;58:1–25. Cortese MM, Parashar UD, Centers for Disease C, Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Dept of Health & Human Services, Centers for Disease Control and Prevention. 2009;58:1–25.
7.
go back to reference WHO. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Department of Immunization, Vaccines and Biologicals.2008. WHO. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Department of Immunization, Vaccines and Biologicals.2008.
8.
go back to reference WHO. Rotavirus vaccines. Wkly Epidemiol Rec. 2009;51-52(84):533–40. WHO. Rotavirus vaccines. Wkly Epidemiol Rec. 2009;51-52(84):533–40.
9.
go back to reference Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011;30(1):S1.CrossRefPubMed Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011;30(1):S1.CrossRefPubMed
10.
go back to reference CDC. Rotavirus vaccine. Atlanta: National Immunization Program, US Department of health and human service; 2010. CDC. Rotavirus vaccine. Atlanta: National Immunization Program, US Department of health and human service; 2010.
12.
go back to reference WHO. Rotavirus vaccines:an update. Wkly Epidemiol Rec. 2009;84(50):533–40. WHO. Rotavirus vaccines:an update. Wkly Epidemiol Rec. 2009;84(50):533–40.
13.
go back to reference General Authority for Information. Statistical Book. Tripoli, Libya: Libya Government; 2009. General Authority for Information. Statistical Book. Tripoli, Libya: Libya Government; 2009.
14.
go back to reference Abugalia M, Cuevas L, Kirby A, Dove W, Nakagomi O, Nakagomi T, et al. Clinical features and molecular epidemiology of rotavirus and norovirus infections in Libyan children. J Med Virol. 2011;83(10):1849–56.CrossRefPubMed Abugalia M, Cuevas L, Kirby A, Dove W, Nakagomi O, Nakagomi T, et al. Clinical features and molecular epidemiology of rotavirus and norovirus infections in Libyan children. J Med Virol. 2011;83(10):1849–56.CrossRefPubMed
15.
go back to reference Ghenghesh KS, Franka EA, Tawil KA, Abeid S, Ali MB, Taher IA, et al. Infectious acute diarrhea in Libyan children: causative agents, clinical features, treatment and prevention. Libyan J Infect Dis. 2008;2:10Ö19. Ghenghesh KS, Franka EA, Tawil KA, Abeid S, Ali MB, Taher IA, et al. Infectious acute diarrhea in Libyan children: causative agents, clinical features, treatment and prevention. Libyan J Infect Dis. 2008;2:10Ö19.
16.
go back to reference Ghenghesh KS, Kreasta M, El-Bakoush M, Tobgi R. Rotaviruses-Associated gastroenteritis. Med J. 2002;2:12–7. Ghenghesh KS, Kreasta M, El-Bakoush M, Tobgi R. Rotaviruses-Associated gastroenteritis. Med J. 2002;2:12–7.
17.
go back to reference Kalaf RN, Elahmer OR, Zorgani AA, Ghenghesh KS. Rotavirus in children with diarrhea in Tripoli, Libya. Libyan J Med. 2011;6:10.CrossRefPubMedCentral Kalaf RN, Elahmer OR, Zorgani AA, Ghenghesh KS. Rotavirus in children with diarrhea in Tripoli, Libya. Libyan J Med. 2011;6:10.CrossRefPubMedCentral
18.
go back to reference NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. Surveillance department at NCIDC 2007;61-64. NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. Surveillance department at NCIDC 2007;61-64.
19.
go back to reference NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. Surveillance department at NCIDC 2008; 61-64. NCIDC, (National Center for Infectious disease Prevention and Control in Libya). Annual report for infectious disease in Libya. Surveillance department at NCIDC 2008; 61-64.
20.
go back to reference Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279(17):1371.CrossRefPubMed Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279(17):1371.CrossRefPubMed
21.
go back to reference Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr. 2008;26(4):388.PubMedPubMedCentral Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr. 2008;26(4):388.PubMedPubMedCentral
22.
go back to reference Nelson EAS, Tam JS, Yu L-M, Ng Y-C, Bresee JS, Poon K-H, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis. 2005;192(Supplement 1):S64–70.CrossRefPubMed Nelson EAS, Tam JS, Yu L-M, Ng Y-C, Bresee JS, Poon K-H, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis. 2005;192(Supplement 1):S64–70.CrossRefPubMed
23.
go back to reference NCDC. Annual report for infectious disease in Libya. Surveillance department at NCDC 2007. NCDC. Annual report for infectious disease in Libya. Surveillance department at NCDC 2007.
24.
go back to reference Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ. 2013;346:f3726.CrossRefPubMedPubMedCentral Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ. 2013;346:f3726.CrossRefPubMedPubMedCentral
25.
go back to reference Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med. 2011;365(12):1108–17.CrossRefPubMed Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med. 2011;365(12):1108–17.CrossRefPubMed
Metadata
Title
Anticipating rotavirus vaccines – a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13
Authors
Salem Alkoshi
Eyal Leshem
Umesh D Parashar
Maznah Dahlui
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1400-7

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue